PERSONALIZED GENE THERAPY TREATMENTS FOR CANCER MARKET ANALYSIS
Key Developments
Major government bodies and NGOs are focused on supporting R&D in personalized gene therapies for cancer. For instance, in August 2019, The National Cancer Institute of the National Institutes of Health (US) awarded Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis with a US$ 15 million grant in a research to investigate the genetic changes that cause acute myeloid leukemia.
Similarly, in August 2019, The Leukemia & Lymphoma Society (LLS) increased pediatric cancer research funding through US$ 50 million Children’s Initiative by adding 20 new grants valued at over US$ 13.8 million to its 2019 portfolio. The LLS aims for the treatment of leukemia & lymphoma patients with multiple targeted therapies simultaneously at up to 200 clinical sites worldwide.
Major institutes are focused on R&D of novel approaches in personalized gene therapies for cancer. For instance, in August 2019, researchers from the Institute of Cancer Research, London, reported use of Artificial Intelligence and Machine Learning to identity five new subtypes of breast cancer. The development reported in the journal NPJ Breast Cancer is expected to aid in development of personalized diagnostics and gene therapies.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
